보포스트 그룹
평가액
$8.499B
보유 종목
30
상위 10 비중
72.8%
보유 종목
30종목| 종목 | 보유수량 | 평가액 ▼ | 신고가 | 현재가 | ±신고 | 52주 | 비중 |
|---|---|---|---|---|---|---|---|
| LIBERTY GLOBAL PLC | 43,958,295 | $1.046B | $23.79 | - | - | - | 12.3% |
| VIASAT INC | 13,732,068 | $1.034B | $75.32 | $67.72 | -10.1% | $30.35 – $89.81 | 12.2% |
| Fox Corp. | 27,322,720 | $861.6M | $31.54 | $68.42 | +117.0% | $48.79 – $76.11 | 10.1% |
| EBAY INC | 16,646,000 | $648.9M | $38.98 | $120.92 | +210.2% | $79.41 – $125.15 | 7.6% |
| CHENIERE ENERGY INC | 10,139,133 | $639.4M | $63.06 | $308.75 | +389.6% | $188.83 – $330.32 | 7.5% |
| BRISTOL-MYERS SQUIBB CO | 10,000,000 | $507.1M | $50.71 | $63.43 | +25.1% | $45.79 – $68.09 | 6.0% |
| CBS Corp. | 12,000,000 | $484.4M | $40.37 | - | - | - | 5.7% |
| QORVO INC | 5,681,181 | $421.2M | $74.14 | - | - | - | 5.0% |
| COLONY CAP INC NEW | 49,687,370 | $299.1M | $6.02 | - | - | - | 3.5% |
| PG&E CORP | 24,500,000 | $245M | $10.00 | $13.25 | +32.5% | $11.95 – $19.11 | 2.9% |
| NEXSTAR MEDIA GROUP INC | 2,000,000 | $204.6M | $102.31 | $207.94 | +103.2% | $154.70 – $253.64 | 2.4% |
| UNIVAR INC | 9,500,000 | $197.2M | $20.76 | - | - | - | 2.3% |
| LIBERTY GLOBAL PLC | 7,657,205 | $189.5M | $24.75 | - | - | - | 2.2% |
| THERAVANCE BIOPHARMA INC | 9,309,168 | $181.3M | $19.48 | - | - | - | 2.1% |
| Fox Corp. | 5,680,307 | $179.2M | $31.54 | $61.11 | +93.8% | $44.39 – $67.76 | 2.1% |
| MCKESSON CORP | 1,306,011 | $178.5M | $136.66 | $1,102.81 | +707.0% | $725.17 – $1,102.81 | 2.1% |
| TRANSLATE BIO INC | 17,544,239 | $172.2M | $9.82 | - | - | - | 2.0% |
| SYNCHRONY FINANCIAL | 5,003,981 | $170.6M | $34.09 | $72.25 | +111.9% | $63.78 – $88.47 | 2.0% |
| TAKEDA PHARMACEUTICAL CO LTD | 9,434,803 | $162.3M | $17.20 | $21.43 | +24.6% | $14.06 – $21.43 | 1.9% |
| NUANCE COMMUNICATIONS INC | 8,245,456 | $134.5M | $16.31 | - | - | - | 1.6% |
| ATARA BIOTHERAPEUTICS INC | 8,308,900 | $117.3M | $14.12 | - | - | - | 1.4% |
| CENCORA INC | 1,166,299 | $96.02M | $82.33 | $359.03 | +336.1% | $252.74 – $374.75 | 1.1% |
| AKEBIA THERAPEUTICS INC | 24,471,453 | $95.93M | $3.92 | $0.47 | -87.9% | $0.40 – $1.76 | 1.1% |
| VERITIV CORP | 3,564,439 | $64.45M | $18.08 | - | - | - | 0.8% |
| ANTERO RESOURCES CORP | 21,087,791 | $63.69M | $3.02 | $38.74 | +1182.8% | $31.38 – $45.15 | 0.7% |
| VISTA ENERGY SAB DE CV | 6,175,000 | $31.93M | $5.17 | $55.84 | +980.1% | $43.88 – $79.25 | 0.4% |
| CARS COM INC | 3,000,000 | $26.94M | $8.98 | $12.71 | +41.5% | $7.58 – $13.56 | 0.3% |
| TRILOGY METALS INC NEW | 12,182,568 | $19.96M | $1.64 | $1.94 | +18.4% | $1.94 – $6.89 | 0.2% |
| GOSSAMER BIO INC | 967,171 | $15.87M | $16.41 | - | - | - | 0.2% |
| PARATEK PHARMACEUTICALS INC | 2,394,498 | $10.34M | $4.32 | - | - | - | 0.1% |
32개 신고 항목을 30개 CUSIP으로 합산했습니다. 위임 운용사별로 나뉜 항목은 합산합니다.
13F는 롱 포지션만(롱옵션 포함, 숏·현금 제외)이며 분기말 기준입니다.
그 외 신고 항목
2건| 종목 | 종류 | 수량·원금 | 평가액 |
|---|---|---|---|
| TESLA INC | 원금 표시(채권·노트) | 300,000,000 | $303.5M |
| THERAVANCE BIOPHARMA INC | 원금 표시(채권·노트) | 30,000,000 | $27.66M |
채권·노트(원금 표시)·선호주·예탁증권·값 없는 항목·옵션(콜·풋)은 참고로 싣되 평가액·종목수에는 세지 않습니다 — 주식수 기준·값 0 초과·옵션 제외·선호주 제외(Dataroma 방식). 옵션은 계약 수가 아니라 기초 주식수와 그 평가액으로 적습니다.